Bicycle Therapeutics (BCYC) Non-Current Debt (2020 - 2024)

Bicycle Therapeutics has reported Non-Current Debt for 5 years, with the latest figure at $8.5 million in Q2 2024.

• For the quarter ending Q2 2024, Non-Current Debt fell 72.13% year-over-year to $8.5 million; the trailing twelve-month figure through Jun 2024 stood at $8.5 million (down 72.13% YoY), and the FY2023 full-year result was $30.7 million, up 1.26% from the prior year.
• Non-Current Debt for Q2 2024 stood at $8.5 million, down from $30.8 million in the prior quarter.
• The five-year high for Non-Current Debt was $30.8 million in Q1 2024, with the low at $8.5 million in Q2 2024.
• Historically, Non-Current Debt has averaged $26.9 million across 5 years, with a median of $30.1 million in 2022.
• Annual changes were most pronounced in 2021 — Non-Current Debt soared 106.23% — and 2024, when it tumbled 72.13%.
• Bicycle Therapeutics' Non-Current Debt stood at $14.5 million in 2020, then jumped by 105.95% to $29.9 million in 2021, then climbed by 1.48% to $30.3 million in 2022, then gained by 1.26% to $30.7 million in 2023, then plunged by 72.29% to $8.5 million in 2024.
• The last three Non-Current Debt figures came in at $8.5 million (Q2 2024), $30.8 million (Q1 2024), and $30.7 million (Q4 2023), per Business Quant data.